Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry

Biemans, VBC; Sleutjes, JAM; de Vries, AC; Bodelier, AGL; Dijkstra, G; Oldenburg, B; Lowenberg, M; van Bodegraven, AA; van der Meulen-de Jong, AE; de Boer, NKH; Srivastava, N; West, RL; Romkens, TEH; Horje, CHTS; Jansen, JM; van der Woude, CJ; Hoekstra, J; Weersma, RK; van Schaik, FDM; Hoentjen, F; Pierik, MJ

Pierik, MJ (corresponding author), Maastricht Univ, Dept Gastroenterol & Hepatol, Med Ctr, POB 5800, NL-6202 AZ Maastricht, Netherlands.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020; 51 (9): 880

Abstract

Background Tofacitinib is a Janus kinase inhibitor approved for the treatment of ulcerative colitis (UC). Aim To evaluate effectiveness, safety and us......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索